Trial intelligence / Profile preview

Long-term bisoprolol in elderly patients with coexisting heart failure and COPD

2013-001312-30Phase 4Active

Sponsor
Università di Napoli Federico II
Start
Jul 2013
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of bisoprolol in chronic obstructive pulmonary disease (COPD) and heart failure (HF) (2 arms), sponsored by Università di Napoli Federico II. Primary endpoint: Reduction of hospitalizations due to COPD exacerbations. Started Jul 2013; status: active.

02

Drugs

bisoprolol
03

Conditions

chronic obstructive pulmonary disease (COPD)heart failure (HF)

Beyond the preview

Go deeper on 2013-001312-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-001312-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call